Read on for updates across the Research we Enable Postmortem Tissue (PMT) Core The Target ALS Postmortem Core has now ...
Invested in Biomarker Innovation ALS is a heterogeneous disease with distinct subpopulations of cases clustering together based on common underlying biology and with distinct differences in the ...
The Target ALS Global Natural History Study (GNHS) is entering a new phase of discovery. As the only international, ...
Predicting Phenoconversion in Carriers of ALS Pathogenic Variants People carrying mutations known to cause ALS make up at ...
Today, we mourn the loss of Brooke Eby. Brooke was a powerhouse. Witty, clever, joyful, and direct. She was unwilling to be ...
Artificial intelligence and machine learning now enable the rapid virtual design and testing of thousands of new molecules and the simulation of their interactions with therapeutic targets. Leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results